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Abstract
The functional outcomes of ephrin binding to Eph receptors (Ephs) range from cell repulsion to
adhesion. Here we used cell collapse and stripe assays to show contrasting effects of human
ephrinA5 binding to EphA2 and EphA4. Despite equivalent ligand-binding affinities EphA4
triggered greater cell collapse, while EphA2-expressing cells adhered better to ephrinA5-coated
surfaces. Chimeric receptors showed the ectodomain is a major determinant of cell response. We
report crystal structures of EphA4 ectodomain alone and in complexes with ephrinB3 and
ephrinA5. These revealed closed clusters with a dimeric or circular arrangement in the crystal
lattice, contrasting with extended arrays previously observed for EphA2 ectodomain. Localization
microscopy-based analyses showed ligand-stimulated EphA4 induces smaller clusters than
EphA2. Mutant Ephs link these characteristics to interactions observed in the crystal lattices,
suggesting a mechanism by which distinctive ectodomain surfaces determine clustering, and
thereby signalling, properties.
Keywords
cell adhesion; cell repulsion; receptor clustering; receptor cis interaction; Eph–ephrin crystal
structures; Eph ectodomain
The fourteen Erythropoetin-producing hepatocellular receptors (Ephs) comprise the largest
family of receptor tyrosine kinases in humans. Eph receptor signalling can exert localised
effects on cytoskeletal dynamics, thereby directing repulsive or migratory responses. Family
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members are expressed in many tissues during morphogenesis, and play essential roles in
cell–cell communication to guide cell positioning, segregation and migration in tissue
homeostasis as well as in development1–3. Conversely, Ephs are widely expressed in cancer
cells and in tumor blood vessels; they are implicated in tumor progression and metastatic
spread, with examples of both increased and decreased levels of expression linked to
malignancy4–6.
Eph receptors bind protein ligands, the Eph receptor-interacting proteins (ephrins), presented
on the surface of an opposing cell (i.e. a trans mode of ligand-receptor binding requiring
direct cell–cell contact). All eight members of the human ephrin family are membrane-
tethered, either by a glycosylphosphatidylinositol (GPI) anchor in the ephrinA proteins, or
by a transmembrane helix and short cytoplasmic region in the ephrinB proteins. The Eph
family is also subdivided into two classes, EphAs and EphBs; groupings that are in part
determined by sequence similarity, but also reflect the general preference of EphA receptors
to bind ephrinA ligands and EphB receptors to bind ephrinB ligands7. Within classes
ephrin–Eph binding is relatively promiscuous, although measurements of binding affinities
reveal some potential for selectivity in the intra-class ligand–receptor pairings8–10.
All Eph receptors share a conserved domain composition1 (Fig. 1a). The ectodomain
comprises an N-terminal ligand-binding domain (LBD), a cysteine rich region, which can be
divided into a sushi domain and an epidermal-growth-factor-like domain (EGF), followed
by two fibronectin type III domains (FN1 and FN2). A single transmembrane helix connects
to the intracellular tyrosine kinase domain and a sterile-alpha motif (SAM) domain that can
carry a C-terminal PDZ binding motif. Likewise the ephrins are characterised by the
conserved architecture of an N-terminal receptor-binding-domain (RBD). The ephrin RBD
conforms to a ‘Greek key’ β barrel fold of eight β strands (designated A–K) and the Eph
LBD consists of a β sandwich ‘jellyroll’ fold of twelve β strands (A–M). Structural studies
of complexes between the Eph LBD and the ephrin RBD have revealed a conserved 1:1
interaction interface that is generic to all ligand-receptor combinations10. This high affinity
binding mode is, in essence, insertion of a single long loop from the ephrin RBD (loop G–H)
into a substantial cavity in the surface of the Eph LDB. The detailed architecture of this
RBD–LBD interface determines the specificity and binding affinity of ephrin–Eph
interactions10. However, the 1:1 ligand–receptor binding mode does not, in isolation,
provide a molecular mechanism for Eph receptor kinase autophosphorylation and signalling.
Eph signalling requires receptor clustering11.
The first crystal structure for an Eph–ephrin complex, namely EphB2 LBD in complex with
ephrinB2 RBD, highlighted a tetrameric arrangement involving a second, low affinity Eph–
ephrin interaction surface. The region of the Eph LBD contributing to this interaction was
designated the HI-loop12. Functional data13 provided support for the biological significance
of the tetrameric arrangement, however, crystallographic studies for a series of other Eph
LBD–ephrin RBD complexes only revealed interfaces mediating the 1:1 high affinity
binding mode10. Subsequent structural and functional studies on the full EphA2 ectodomain
identified two in-cis Eph–Eph dimerisation surfaces which are equally essential for EphA2
clustering at cell–cell contacts14,15. These are a polar region on the LBD that includes the
HI-loop plus adjacent surfaces, and a hydrophobic region on the sushi domain. Together,
these interactions promote the assembly of extended EphA2 arrays that can form in the
presence or absence of ephrin14,15.
The functionality of the ephrin–Eph system is complex. Depending on receptor and ligand
availability, as well as cell specific factors, Eph signalling mediates responses ranging from
cell repulsion to adhesion. This variation in cellular response complicates dissection of
fundamental molecular mechanisms in ephrin–Eph signalling. Eph ectodomain binding to
Seiradake et al. Page 2
Nat Struct Mol Biol. Author manuscript; available in PMC 2014 March 04.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
the receptor-binding-domain (RBD) of class A or B ephrin ligands on neighbouring cells
classically triggers cell–cell repulsion through activation of the Eph intracellular kinase
domain1. In the nervous system, repulsive EphA4–ephrin interaction is required for the
formation of precise neuronal connections in the brain16,17 and spinal cord18, and for motor
and sensory innervation of peripheral targets19,20. Although EphA2 protein is found in
axons21, its overall expression in the brain is low22. It is expressed in many other tissues22
including the eye lens, where EphA2–ephrinA5 interaction is implicated in the adhesive
packing of fibre cells through cross-talk with cadherin and catenin family proteins23. EphA2
is also associated with invasive cell behaviour and is up-regulated in many cancers where it
increases cancer malignancy and poor clinical prognosis4.
EphA2 only binds to class A ephrins, while EphA4 is unusually promiscuous, binding
ephrinAs and Bs7,8,24. Both Ephs bind ephrinA5. To investigate the potential role of Eph
receptor clustering characteristics in cellular response we carried out a comparative
structural and functional analysis of the EphA2–ephrinA5 and EphA4–ephrinA5 systems.
RESULTS
Eph dependent differences in cellular response to ephrinA5
Whilst many factors can contribute to the functional outcome of Eph activation, we asked if
Eph receptors themselves possess intrinsically distinctive properties which generate different
cell responses. Cell rounding assays are widely used model systems for repulsive signalling
and have been used to study Eph signalling upon stimulation with pre-clustered ephrins25.
Cytoskeleton collapse, cell rounding, and de-adherence result from Eph kinase activation.
As ligand binding affinity and kinetics could contribute to functional outcome we first
sought to control for this factor. To do so we investigated the relative binding affinities of
ephrinA5 to EphA2 and EphA4 in surface plasmon resonance assays. Consistent with
previous ELISA-based reports9, we found that ephrinA5 binds with similar affinity to
EphA2 and EphA4 (data not shown). We engineered constructs in which full length,
transmembrane, mouse EphA4 and human EphA2 receptors were fused to a fluorescent
protein tag (mVenus), and expressed them in HeLa or COS7 cells (see Online Methods).
Transiently transfected cells expressed EphA2 and EphA4 at comparable levels after ~20
hours (Supplementary Fig. 1). We found that EphA4-transfected cells undergo significantly
stronger rounding in response to pre-clustered ephrinA5-Fc compared to EphA2-transfected
cells (Fig. 1b, Supplementary Fig. 2 and Supplementary movies 1 and 2). Consistent with
the low level of collapse observed with untransfected control cells, we did not detect
endogenous EphA2 or EphA4 in our HeLa cell cultures (Fig. 1b and Supplementary Fig. 1).
Conversely, in a stripe assay, we found that EphA2-transfected HeLa cells adhere strongly
to ephrinA5-Fc coated stripes, while EphA4-transfected cells distribute more randomly
between control and ephrinA5-Fc-coated stripes (Fig. 1c). What determines these Eph-
specific signalling responses?
EphA4 unliganded and liganded crystal structures
To dissect the molecular properties that distinguish EphA4 ectodomain (EphA4ecto) from
EphA2 ectodomain (EphA2ecto), we solved four crystal structures for the complete
EphA4ecto, in its unliganded form (to 3.65Å resolution), in complex with ephrinB3 RBD (1
crystal, 4.65Å) and in complex with ephrinA5 RBD (two crystals: lysine-methylated, 4.0Å,
and native, 4.95Å). Data statistics, and the highest resolution shells using the CC1/2
criteria26 or data quality of I/σ(I) > 2 are provided in Table 1. Human EphA4ecto and ephrin
RBD proteins were expressed in HEK293S GnTI− cells, crystallized, and the structures
phased by molecular replacement (see Online Methods and Supplementary Note). The
unusually high solvent content of the crystals (76–88%) in conjunction with solvent
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flattening methods produced good quality electron density maps despite the generally low
resolution of the diffraction data sets (Table 1 and Supplementary Fig. 3). We maintained
strong stereochemical restraints for refinement of the unliganded EphA4ecto structure and
the lysine-methylated EphA4ecto ephrinA5 RBD complex. For the native EphA4ecto
ephrinA5 RBD and EphA4ecto ephrinB3 RBD complexes we limited refinement to rigid
body and TLS (Translation Libration Screw-motion) of the individual domains;
stereochemical outlier residues present in high resolution molecular replacement models
were not altered for these two lowest resolution structures. All four crystal structures have
greater than 95% of residues in the favoured regions of the Ramachandran plot (and 0.0 –
0.4% in disallowed regions) as assessed using Molprobity27.
The domain arrangement within EphA4ecto is similar to that of EphA2ecto14,15, with
sequential LBD, sushi, EGF, FN1 and FN2 domains resulting in an oblong molecule with a
~ 90° kink at the FN1–FN2 linkage (Fig. 2a). Unlike in EphA2ecto14,15, the EphA4 FN1–
FN2 linker conformation and relative orientation of the FN1 and FN2 domains is conserved
in all four crystal structures, suggesting rigidity (Supplementary Fig. 4). The amino acid
sequences of EphA2 and EphA4 in the FN1–FN2 linker region are not conserved and
include a potential N-linked glycosylation site in EphA2, but not EphA4. Also, the EphA4
FN2 domain packs closely against the FN1 domain using loop residues 518–520 (Ala–Ala–
Gly). Two of these residues are replaced by bulkier and more hydrophilic amino acids for
the corresponding residues 512–514 in EphA2 (Gln–Glu–Gly). Taken together, these
differences may underlie the reduction in inter-domain rigidity for this region in EphA2
relative to EphA4. The functional consequences of these differences in rigidity are unclear,
but given the proximity of FN2 to the plasma membrane, they may impact on receptor-
membrane interactions and orientation at the cell surface.
All reported structures of EphA2ecto revealed continuous array-like arrangements within the
crystal lattice, compatible with EphA2 clustering in cis on the cell membrane14,15
(Supplementary Fig. 5). Here we show that EphA4ecto does not form extended EphA2-like
arrays in the crystal, but defined units. The EphA4ecto units that are compatible with in-cis
interaction in the context of a cell surface are composed of two, three or six copies of EphA4
in a dimeric or circular arrangement (Fig. 2b). These structural data suggest that the mode of
clustering observed in EphA2 cannot be extrapolated to all Eph family members.
Superposition of the EphA4ecto structure (unliganded or bound to ephrin) on EphA2ecto as
arranged in its characteristic arrays does not lead to obvious clashes. We conclude that
surface properties, rather than differences in the overall shape, determine the mode of Eph
ectodomain clustering. EphA2ecto arrays form through Eph–Eph interactions mediated by
two specific surface patches, one centred on the HI-loop of the LBD and one on the sushi
domain14,15 (Supplementary Figs. 5 and 6). The structures reported here show that the
EphA4 sushi domain can also mediate Eph–Eph interaction using the equivalent surface
patch, often through dimerisation as found in EphA2ecto structures14,15. In contrast, the less
conserved HI-loop region on the LBD mediates no EphA4–EphA4 contacts in three of the
four EphA4ecto structures presented (Fig. 3 and Supplementary Figs. 6 and 7). It provides
Eph–Eph contacts only in the crystal structure derived from lysine-methylated EphA4ecto–
ephrinA5 RBD complex (Supplementary Fig. 8), but as the EphA4 HI-loop contains a lysine
(Fig. 3b), it may have non-native properties in this sample. Taken together, the data show
that, of the two EphA2 surfaces required to build up EphA2ecto arrays, only one, henceforth
termed the sushi dimerisation surface, is functionally conserved in EphA4 as an Eph–Eph
interaction surface. The structural results further suggest that one such interaction surface is
not sufficient to support the formation of EphA2-like arrays. Might Eph response to ligand
be modulated by the structurally encoded clustering properties of the receptors’
ectodomains?
Seiradake et al. Page 4
Nat Struct Mol Biol. Author manuscript; available in PMC 2014 March 04.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Eph ectodomain clustering characteristics and function
To test whether differences in the clustering properties of the EphA2 and EphA4
ectodomains play a functional role in the cell, we first produced chimeras of the full length,
mVenus-tagged, transmembrane receptors, in which the ectodomains of EphA2 and EphA4
were swapped (Fig. 4a). Expression levels in HeLa cells were similar to the wild type
receptors (Supplementary Fig. 1). Indeed, the cell rounding assays showed the EphA4
ectodomain produced more collapse compared to EphA2 ectodomain (Fig. 4b), indicating
that the Eph ectodomain is the major determinant defining the response. However, swapping
the ectodomains of EphA2 and EphA4 did not fully switch the receptor functionality,
suggesting that the identity of the transmembrane helix and/or the cytoplasmic region also
contribute to the cell response, possibly through distinct steric or protein interaction
properties in these regions. Next we sought to test whether the ectodomain-dependent
functional differences relate to their clustering properties.
To directly characterize the clustering properties of fluorescently tagged EphA2 and EphA4
in COS7 cells, we used time lapse and localization microscopy techniques in living and
fixed cells, respectively. Our COS7 cells expressed no EphA4 and moderate levels of
endogenous EphA2 (Supplementary Fig. 1). In live cell imaging we found that EphA2
clusters formed at the cell surface within minutes after the addition of pre-clustered
ephrinA5-Fc, initially with increased abundance of clusters at the cell periphery (Fig. 4c and
Supplementary Fig. 9). 15-30 minutes after stimulation, EphA2 was found in large endocytic
vesicles, thereby essentially clearing the cell membrane of the receptor (Supplementary Fig.
9 and data not shown). In contrast, EphA4 formed relatively small clusters and vesicles at
the cell surface under the same conditions (Fig. 4c and Supplementary Fig. 9).
In order to gain quantitative information on the Eph clusters we analysed fixed cells,
implementing one of the recently developed methods of super-resolution fluorescence
microscopy. Spectral position determination microscopy (SPDM)28 is a form of localization
microscopy (also termed direct stochastic optical reconstruction microscopy; dSTORM29)
that is applicable for standard fluorophores such mVenus. An intense laser excitation of the
sample shifts all the fluorophores into a long-lived dark state. The stochastic recovery of
individual molecules to the relatively short lived fluorescent state then separates their signals
over time (and with sequential image acquisition also provides separation in space) allowing
the positions of single molecules to be determined with very high accuracy. We collected
data sets of individual molecular positions of mVenus-tagged wild type and chimeric Ephs
in paraformaldehyde-fixed samples of COS7 cells (non-stimulated or 10 minutes post-
addition of pre-clustered ephrinA5-Fc). We chose cells showing similar Eph expression
levels and analysed the distribution of distances between receptor positions. To detect
deviations from a spatially homogeneous distribution, i.e. clustering, we used the Ripley’s
L-function30, which essentially shows the normalized distribution of distances between the
single molecule positions (see Online Methods). A random distribution will approximately
follow the horizontal zero-axis with constant dispersion only if the data follow a
homogeneous Poisson process. Signals above zero therefore reflect both the amount of
clustering (y values) and cluster diameter (x values). A further analysis of the receptor
clusters was performed using a method31 based on a threshold of local molecule density to
identify and characterize individual clusters in the data sets (see Online Methods). The
chimeric Eph receptors revealed that the ectodomain strongly drives the clustering properties
(Fig. 4d, e and Supplementary Figs. 9 and 10). Interestingly, small clusters for EphA4
correlated with small units found in the EphA4ecto crystals, while larger clusters correlated
with the extended arrays described for EphA2ecto.
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The molecular determinants of clustering
In order to identify whether the molecular determinants responsible for the differing
functional effects were those mediating Eph–Eph interactions in the lattice assemblies of the
crystal structures we designed a panel of mutant Eph-mVenus tagged constructs. EphA2su
and EphA4su each contain the multiple mutations L254D V255D I257D in the sushi
dimerisation surface. To target the EphA2 HI loop that mediates Eph–Eph contacts
specifically in EphA2ecto crystal structures, we used the G131Y mutant EphA2HI. In
localization microscopy we found that mutations in the HI loop (construct EphA2HI) or in
the sushi dimerisation surface (construct EphA2su) reduced EphA2 clustering to a level
closer to that of EphA4 (Fig. 4d, e). To further validate this result we introduced a second
EphA2 sushi mutant, EphA2su2, containing an N-type glycosylation site in the sushi
dimerization surface (H246N A248S). The bulky sugar in this region of EphA2su2 reduced
clustering of the receptor even further compared to EphA2su (Fig. 4d). EphA2su had EphA4-
like characteristics also in cell rounding and stripe assays (Fig. 4f). Thus targeting the array-
forming abilities of EphA2 can convert its function. The equivalent mutant EphA4su, also
showed reduced clustering compared to wild type EphA4 (Fig. 4d). However, the overall
clustering response of wild type EphA4 was low, and this further reduction was not
significant.
In sequence comparisons between Ephs the sushi dimerisation surface is highly conserved,
suggesting it may mediate a conserved (Eph–Eph) interaction mode across all family
members, with the possible exception of EphB4 (Supplementary Fig. 11). In contrast,
sequence variation in the HI-loop is high. Nevertheless, Gly131, which we show here is
important in EphA2 clustering, is conserved in all EphAs except for EphA4 (Supplementary
Fig. 11). It remains to be seen whether the other EphA receptors have EphA2- or EphA4-
like clustering characteristics.
Ligand independent recruitment to clusters
Previously reported fluorescence microscopy data for EphA3 (ref. 32) suggested that ephrin-
independent Eph–Eph association can increase the size of clusters. To test whether the
strong EphA2 clustering response observed in COS7 cells involves Eph–Eph association
independently of ephrin-binding, we co-expressed in the same cell EphA2 (mCherry-tagged)
and the non-ephrin-binding mutant EphA2nb (mVenus-tagged). EphA2nb contains mutation
A190N L192S to sterically hinder high affinity ephrin binding through creation of an N-
linked glycosylation site. We found, using live cell imaging, that EphA2nb is recruited into
clusters of stimulated wild type EphA2 (Fig. 5a). When expressed on its own, EphA2nb did
not cluster in response to ephrinA5-Fc addition (not shown). To find out whether the
recruitment of EphA2nb into EphA2 clusters depended on the array-forming Eph–Eph
interaction surfaces, we co-expressed EphA2 with the non-ephrin binding mutant
EphA2nb-su, which combined the mutations in the sushi dimerisation surface (L254D
V255D I257D) and in the ephrin-binding site (A190N L192S). In agreement with the
crystallographic results, EphA2nb-su was not recruited into wild type EphA2 clusters (Fig.
5b). Supplementary Movies 3–10 show time lapse experiments of Eph clustering
experiments.
DISCUSSION
The different members of the Eph receptor family are responsible for a myriad of often
opposing functions including cell–cell adhesion and repulsion1,4. EphA4 is best known for
its role as a classical guidance receptor in the neuronal system where it controls cell
dynamics and motility mostly through repulsive signalling16–19. EphA2 has been
extensively studied for its function in controlling cell adhesion, motility and invasiveness in
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a variety of tissues, especially in many cancers4. Most previous efforts to dissect the
different functionalities of Ephs have focused either on the ephrin-binding specificities1,33 or
the intracellular interactions with downstream signalling proteins1,34. A recent study
suggested that EphA2 clustering propensities can impact on function, although the
underlying mechanisms remained unclear35. We are now able to address this issue by
structural comparison of Eph ectodomain assemblies. We found that Ephs within the same
class, EphA2 and EphA4, have distinct ectodomain properties that can determine differential
clustering, albeit with the caveat that a simple swap of ectodomains does not entirely switch
the receptor functionality. These results demonstrate that, together with the functional
contributions of the intracellular domains, the distinctive extracellular clustering
characteristics can modulate signalling responses of the full length receptor. The HI-loop
and its adjacent regions on the LBD harbour some of these receptor-specific features. Early
structural studies using EphB2 LBD and ephrinB2 RBD implicated this region (then termed
the “specificity loop”) in secondary Eph–ephrin interactions that give rise to circular Eph–
ephrin hetero-tetramers12. The functional importance of Eph surfaces mediating hetero-
tetramerisation were further confirmed in a mutagenesis study13. More recently, we and
others presented structural data for complete EphA2 ectodomains and found that for these,
the EphA2 HI-loop is part of a large homo-typic Eph–Eph interaction surface contributing to
EphA2 array formation in cis. These results led to a new array-based model for Eph
clustering14,15. The data reported here reveal that there is no single generic arrangement for
Eph cluster formation, but rather that the different modes of interaction involving the HI-
loop region reflect a diverse functional repertoire. The sushi dimerisation surface is the only
surface which shows a conserved (Eph–Eph) interaction mode. In the absence of additional
Eph- or ephrin-mediated interactions this surface can give rise only to dimeric, but not
multimeric arrangements. It is therefore necessary, but not sufficient for array-like
clustering.
Our results suggest a model in which different Eph ectodomain interaction properties are
capable of dramatic modulation of signalling outputs providing an additional level of
control. This model allows structural fine-tuning of functional output in cells co-expressing
different Eph receptors, given their ability to form hetero-oligomeric Eph clusters36,37,
presumably through the conserved sushi dimerisation surface. The Ephs may thus exemplify
a novel mechanism whereby a relatively small number of distinct receptors can control the
vast number of diverse signalling processes, associated with the complexity we find in
higher organisms.
EphA2 is notorious for its oncogenic effects in many cancers4,5,35. These effects have been,
at least in part, linked to Eph kinase-independent clustering properties38 as well as more
generally to the level of the receptor–ligand clustering and activation6. In the results
reported here we demonstrated that, by targeting surfaces involved in EphA2 clustering, we
can convert EphA2 activity to resemble repulsion-mediating EphA4. The correlation of
EphA2 clustering ability with breast cancer cell malignancy35 renders this mechanism for
altering cellular response therapeutically relevant. Classically, efforts in targeting Eph
functions in cancers have aimed at the kinase and ligand-binding functions of the receptor,
or at regulating the overall expression levels4. Our results highlight the potential of a
perhaps more distinctive approach in which Eph receptor function can be controlled by
modulation of its clustering properties.
ONLINE METHODS
Vectors and Cloning
Transmembrane constructs coding for human EphA2 (residues 27–976, Uniprot: P29317)
and mouse EphA4 (residues 28–986, Uniprot Q03137) were fused to an N-terminal flag tag
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(TGDYKDDDDK). Chimeric construct A2A4 was produced by fusing EphA2 ectodomain
(residues 27–534) to EphA4 transmembrane and intracellular regions (residues 548–986)
and an N-terminal flag tag. Chimeric construct A4A2 was produced by fusing EphA4
ectodomain (residues 28–547) to EphA2 transmembrane and intracellular regions (residues
535–976) and an N-terminal flag tag. Point mutants were generated using polymerase chain
reaction techniques. All transmembrane Eph constructs were cloned into the AgeI–KpnI
cloning site of a modified pHLsec vector39 coding for an N-terminal secretion signal
sequence and a C-terminal mVenus or mCherry tag followed by a polyhistidine tag.
Secreted ectodomains of human EphA4 (EphA4ecto, residues 20–547, Uniprot: P54764) and
human ephrin RBDs (ephrinA5, residues 27–166, Uniprot: P52803, ephrinB3, residues 27–
169, Uniprot: Q15768, ephrinB2, residues 27–167, Uniprot: P52799) were cloned into the
AgeI–KpnI sites of a pHLsec vector39 coding for an N-terminal secretion signal sequence
and a C-terminal poly-His tag.
Protein purification and crystallization
We expressed EphA4ecto, ephrinA5 RBD and ephrinB3 RBD transiently39 in GnTI-deficient
HEK293S cells40. Proteins were purified separately from cell culture medium using Ni-
affinity and size-exclusion chromatography. Complexes were formed by mixing either
before or after de-glycosylation with endoglycosidase F1 (refs. 39, 41) and subsequent
lysine-methylation using established protocols42 (see Supplementary Note). All crystals
were grown at 20 °C in sitting drops using vapour diffusion43. Crystals of unliganded
EphA4ecto were produced by mixing the concentrated EphA4ecto and ephrinB2 RBD
solution (see Supplementary Note) in a 1:1 ratio (v/v) with crystallization solution 1 (1.8 M
ammonium phosphate, 100 mM Hepes pH 7.4). Crystals of lysine-methylated EphA4ecto in
complex with ephrinA5 RBD grew by mixing concentrated sample 1:1 (v/v) with
crystallization solution 2 (8 % w-v Polyethylene Glycol 8000 and 0.1 M Tris-HCl pH 8.5).
Native crystals of EphA4ecto in complex with ephrinA5 RBD grew by mixing concentrated
sample 1:1:1 (v/v/v) with crystallization solution 3 (0.01 M MgSO4, 1.8 M LiSO4, 0.05 M
Sodium Cacodylate pH 6) and 4% benzamidine-HCl (Hampton). Native crystals of
EphA4ecto in complex with ephrinB3 RBD grew by mixing concentrated sample 1:1:1 (v/v/
v) with crystallization solution 4 (0.08 M magnesium acetate tetrahydrate. 0.05 M
cacodylate pH 6.5, 15% polyethylene glycol 400) and 0.1 M spermidine (Hampton).
Structure determinations
Diffraction data were collected at the Diamond Light Source (beam lines I24, I04, I04-1) at
100 K. Crystals were flash-frozen after brief dipping into reservoir solution supplemented
with 15–25% glycerol. Diffraction data were processed using XIA244, XDS45, MOSFLM46
and CCP4 suite programs47. The structure of unliganded EphA4ecto was solved using
subdomains of the previously published EphA2ecto model (PDB accession code 2X10)14 as
inputs for molecular replacement in PHASER48. The resultant model was improved using
the MR_ROSETTA49 implementation in PHENIX50. Electron density modification was
done with PARROT51, manual improvement of the model in COOT52 and final rounds of
refinement in autoBUSTER53, using strong stereochemical restraints and TLS. The resultant
model was used to phase the data for lysine-methylated EphA4ecto in complex with
ephrinA5 RBD. The structure of ephrinA5 RBD, as found in complex with EphA2ecto (PDB
accession code 2X11), was placed manually by superposition. Individual domains were
refined using rigid body refinement in PHASER50 and minor adjustments were performed
by hand in COOT52. Electron density modification was done with PARROT51. A final
round of refinement was done in autoBUSTER53, using strong stereochemical restraints and
TLS. The resultant model was used to phase the data for native EphA4ecto in complex with
ephrinA5 RBD. We used the refinement program in PHENIX50 and REFMAC554 for rigid
body and TLS refinement of individual domains. Electron density modification was done
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with PARROT51. The structure of EphA4ecto in complex with ephrinB3 RBD was solved
using the model for unliganded EphA4ecto and the model for ephrinB3 RBD as found in
complex with the Nipah virus G attachment glycoprotein (PDB accession code 3D12)55.
Rigid body and TLS refinement were done in PHENIX56 and BUSTER53, electron density
modification in PARROT51.
HeLa cell collapse assay
HeLa cells were grown in life cell imaging chambers (Lab-Tek Cat. no. 155380) at 37 °C in
Dulbecco’s Modified Eagle’s Medium (DMEM, 4.5 g/l glucose, + L-glutamine, no
pyruvate, Gibco) supplemented with 1x L-glutamine (PAA), 10% foetal calf serum
(HyClone) and 1x penicillin + streptomycin (PAA). Cells were transfected with Fugene or
X-tremeGene HP DNA transfection reagent (Roche) following the recommended protocol
and using 0.2 μg plasmid DNA per ml. After 12–15 hours, the medium was changed to
imaging medium (DMEM [Cat. no. P04–05545, PAN Biotech GmbH] supplemented with
1x L-glutamine, 0.5% foetal calf serum (HyClone) and 1x penicillin + streptomycin (PAA)
and the cells incubated at 37 °C for 2–6 hours. EphrinA5-Fc (R&D Cat. no. 374-EA) at 0.2
mg ml−1 in PBS was mixed with goat anti-human IgG Fcγ (Jackson ImmunoResearch) and
imaging medium in a 5:1:28 ratio, and incubated for 2 hours at room temperature. For
stimulation, the ephrinA5-Fc mixture was further diluted with pre-warmed imaging medium,
and added to the cells in a final concentration of 2 μg ephrinA5-Fc + 0.04 μg anti-IgG per
ml. Cells were imaged using a Zeiss Axiovert 200M microscope equipped with a
temperature-controlled carbon dioxide-incubation chamber set to 37 °C, 65% humidity, 5%
CO2. Illumination was provided by an X-Cite lamp (series 120, Lumen Dynamics Group)
and images were recorded by a Coolsnap HQ camera (Photometrics). Sequential images
were acquired before and every 6 min following pre-clustered ephrin-Fc addition.
MetaMorph imaging software (Molecular Devices) was used to analyse cell collapse
responses and to assemble movies.
COS7 stimulation assay
COS7 cells were cultured, transfected and stimulated with ephrinA5-Fc + anti-human IgG as
described above for HeLa cells. Cells were imaged using a confocal spinning disc
microscope (Zeiss AXIO Observer Z1) and temperature-controlled incubation chamber
(Zeiss) set to 37 °C, before and every 4 minutes after stimulation at 63 × magnification. 0.5
μm Z-stack slices were taken. MetaMorph imaging software was used to pick and project
three in-focus Z-planes per image and to assemble movies.
Localization microscopy based analysis
COS7 cells were cultured and transfected with mVenus-tagged Eph constructs as described
in previous sections. We prepared paraformaldehyde-fixed samples of non-stimulated COS7
cells, and of COS7 cells after 10 minutes of stimulation with ephrinA5-Fc + anti-IgG.
Samples were mounted on regular glass slides using fluorescence mounting medium
(DAKO). An OMX (optical microscope experimental, V2, API) was modified to enable
localization microscopy using conventional fluorescent proteins28. The intensity of the 488
nm laser was adjusted to ~14 kW/cm2 in the object plane to drive the fluorophores into a
long-lived dark state, a stochastic recovery of individual molecules to the fluorescent state
was recorded by image sequences of 2000 frames and an integration time of 50 ms per
frame. The positions of single molecules were calculated with an estimated mean
localization accuracy of < 21 nm using a Maximum-Likelihood based algorithm57 which we
adapted to the OMX hardware configuration. The resulting data sets were sorted according
to their mean point densities (number of molecules recorded per μm2). To control for the
effect of Eph expression-level on clustering, only data sets with similar mean point densities
(~170/μm2) were selected for further analyses. To analyze the distances between
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neighbouring molecule positions we used the Ripley’s L-function30, which takes into
account distances expected for a homogenous distribution and allows interpretation of the
strength of clustering (amplitude) as well as giving an indication of the size and size
variance of clusters (position along the X axis, width of the distribution). Receptor clusters
were identified and analysed using a previously described algorithm31 based on a threshold
value of local point density. For the present analysis the value defining what is regarded as a
cluster was set to >20 molecule positions within a radius of 50 nm (~2670 points/μm2).
Stripe assay
12.5 μg/ml of ephrinA5-Fc protein (R&D Cat. no. 374-EA) was preclustered (ratio 1:3) with
Alexa594-conjugated anti-hFc antibody (Invitrogen, Cat. No. A11014) in PBS for 30 min.
Clustered ephrinA5-Fc was injected into matrices (90 μm width) placed on 60 mm dishes58,
resulting in the first red-fluorescent stripes. After 30 min incubation at 37°C, dishes were
washed with PBS and matrices were carefully removed. The dishes were further coated with
12.5 μg/ml of Fc (Jackson Cat. No. 009-000-008) protein pre-clustered with anti-hFc
(Jackson Cat. No. 109-005-098; no fluorescent dye) for 30 min at 37°C, after that stripes
were washed three times with PBS. HeLa cells, transfected with Fugene HD transfection
reagent (Roche) following the manufacturer’s instructions and using 0.6ug per well (6-well
format), were cultured for 24 h on the stripes (30,000 cells/carpet). Cells were fixed with 4%
PFA in PBS for 20 min at RT and washed with PBS. The mVenus tag in the Eph constructs
was used to visualize transfected cells. Images of cells and stripes were acquired with an
Axioplan epifluorescent microscope (Zeiss) at 10× magnification. Images containing stripes
were further separated into two parts (on red or black stripes). The total numbers of Venus+
pixels on red stripes (ephrinA5-Fc) were quantified using Image J.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Stimulation of EphA2 and EphA4 trigger different cell responses.
a) Schematic overview showing Eph domain composition: ligand-binding domain (LBD),
sushi, epidermal-growth-factor-like (EGF), fibronectin type III (FN1 and FN2),
transmembrane helix (TM), tyrosine kinase and sterile-alpha motif (SAM). Domains are
coloured separately for the ectodomain.
b) Rounding responses of non-transfected control and Eph-transfected HeLa cells upon
ephrinA5-Fc stimulation were measured. Average adherent cell surface areas were
normalized using the values at time =0 (before receptor stimulation). Statistical significance
was determined using one-way ANOVA and Tukey’s post hoc test and is shown with red
stars (control, EphA4) and black stars (EphA2, EphA4). Error bars denote s.e.m. *P < 0.05,
**P < 0.01, ***P < 0.001.
c) Hela cell stripe assay. Adhesion of Eph-transfected cells to ephrinA5-Fc coated surfaces
is shown (50% corresponds to random distribution, > 50% reflects adhesion). Statistical
significance was calculated with one-way ANOVA and Tukey’s post hoc test and is shown
with red stars (to EphA4), blue stars (to EphA2) and grey stars (to control). Error bars
denote s.e.m. **P < 0.01.
Seiradake et al. Page 14
Nat Struct Mol Biol. Author manuscript; available in PMC 2014 March 04.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 2. EphA4 ectodomain forms oligomeric units in crystal lattices.
a) Cartoon diagrams are shown of complete EphA4 ectodomain (EphA4ecto), unliganded or
in complex with ephrinA5 or ephrinB3 receptor-binding domain (RBD). EphA2 domains are
coloured separately as indicated. Ligand-binding domain (LBD), epidermal-growth-factor-
like (EGF), fibronectin type III domains 1 and 2 (FN1 and FN2). Ephrins are coloured in
grey.
b) Crystal lattice assemblies that are compatible with clustering of receptors on the same cell
(in cis) are shown as surface representations for the four crystal structures presented (side
and top views). Colours are as in panel a.
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Fig. 3. Properties of the EphA4 HI-loop area and sushi dimerization region.
a) The surface of EphA4ecto in complex with ephrinB3 RBD is shown in two colour
schemes. Top: domains are coloured separately as in Fig. 2. Bottom: colours are white
(EphA4), grey (ephrinB3), magenta (HI-loop and adjacent regions implicated in clustering
for EphA2 (ref. 14)) and cyan (sushi dimerization surface).
b–e) Zoomed-in view of the EphA4 HI-loop region (magenta) and sushi dimerization
surfaces (cyan). b) Residues are shown as sticks. Lys133 is marked with an arrow. An
asterisk marks Glu134, equivalent to Gly131 in EphA2, which is mutated to tyrosine in
EphA2HI. Three asterisks mark the surface residues Leu254, Val255 and Ile257 on the sushi
domain. These are mutated to aspartate in EphA4su, EphA2su and EphA2nb-su.
c) Colours are according to sequence conservation among human EphAs (ranging from
black = highly conserved, to white = not conserved). The HI-loop area and sushi
dimerization surface are encircled.
d) Colours are according to the frequency of residues mediating lattice contacts in the four
crystal structures presented (ranging from black = involved in all lattices, to white = not
involved in any lattices).
e) Colours are according to electrostatic potential, calculated for vacuum (ranging from blue
= positive charge, to red = negative charge, units in Pymol (DeLano, W. L.) adjusted to +/
−63 . White = neutral).
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Fig. 4. Eph ectodomains can control Eph clustering and function.
a) Schematic representation of transmembrane Eph constructs: EphA2 blue, EphA4 red.
Chimeric proteins were engineered by swapping ectodomains (A2A4 or A4A2). Stars mark
point mutants in the HI-loop, sushi dimerization and major ephrin-binding sites. All
constructs contain an N-terminal Flag tag and a C-terminal mVenus or mCherry tag.
b) HeLa cell rounding responses measured 10 minutes after ephrinA5-Fc stimulation.
Plotted are averaged ratios of the adherent cell surface after and before stimulation.
Statistical significance to EphA2 and EphA4 samples (one-way ANOVA and Tukey’s post
hoc test) is shown with blue and red stars, respectively. A two-tailed T-test was used to
calculate significance between A2A4 and A4A2. Error bars denote s.e.m. *P < 0.05, **P <
0.01, ****P < 0.0001.
c) Confocal time lapse images. Eph clustering was induced by ephrinA5-Fc stimulation in
COS7 cells.
d) Single molecule experiments were performed using localization microscopy. Normalized
Ripley’s L functions (L(r)-r)) are plotted over the distances (r(nm)) between the molecules.
Increased (L(r)-r)) at particular distances reflect the amount of clustering and the cluster
sizes.
e) Further quantification of data presented in panel d. The percentage of detected molecules
present in clusters is shown. Clusters were defined as molecules having at least 20
neighbouring molecules within a radius of 50 nm (Supplementary Fig. 10).
f) Cell rounding in response to pre-clustered ephrinA5-Fc and cell adhesion to ephrinA5-Fc
containing stripes was measured using transfected HeLa cells. EphA2 blue, EphA4 red,
EphA2su grey. Statistical significance was determined using one-way ANOVA and Tukey’s
post hoc test. Error bars denote s.e.m. **P < 0.01, ***P < 0.001, ****P < 0.0001.
Seiradake et al. Page 17
Nat Struct Mol Biol. Author manuscript; available in PMC 2014 March 04.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 5. Non-ligand-bound EphA2 clustering depends on Eph–Eph ectodomain interactions.
a) Live COS7 cell time lapse experiment showing co-clustering of the non-ephrin binding
mutant EphA2nb-mVenus with EphA2-mCherry. Blue arrows indicate a co-clustering event.
b) As in panel a, but using a non-ephrin-binding mutant EphA2nb-su-mVenus with mutations
in the sushi dimerization surface.
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Table 1
EphA4 ectodomain EphA4 ectodomain +
ephrinA5 (methylated)
EphA4 ectodomain +
ephrinA5 (not
methylated)
EphA4 ectodomain +
ephrinB3
Data collection
Space group P3221 H32 H32 P4332
Cell dimensions
 a, b, c (Å) 166.88, 166.88, 192.07 256.95 256.95 252.51 202.88 202.88 326.51 300.53 300.53 300.53
Resolution (Å)a 83–3.65 (3.7–3.65) 70–4.0 (4.05–4.00) 48–4.95 (5.00–4.95) 106–4.65 (4.7–4.65)
Rmeas (%)a,b 19.2 (545) 41.0 (586) 74.3 (558) 26.2 (367)
CC1/2b 100 (17.7) 99.7 (15.9) 95.8 (22.0) 99.9 (16.1)
I / σ(I)a 14.17 (0.48) 7.74 (0.59) 3.32 (0.32) 7.7 (0.50)
Highest resolution shell
with I/σ(I) >2 (Å)
4.2–4.1 4.55–4.45 7.0–6.9 5.8–5.7
Completeness (%)a 99.9 (100) 99.9 (100) 99.7 (98.5) 99.9 (99.9)
Redundancya 20.0 (20.1) 11.3 (11.3) 9.4 (7.6) 10.8 (6.9)
Refinement
Resolution (Å)a 48.2–3.65 (3.76–3.65) 70–4.0 (4.15–4.0) 48–4.95 (5.08–4.95) 106–4.65 (4.84–4.65)
No. reflectionsa 34842 (2951) 27150 (2680) 11147 (744) 25492 (2802)
Rwork / Rfree 0.349 / 0.386 0.313 / 0.321 0.396 / 0.414 0.328 / 0.342
No. atoms (all protein) 6344 5087 5087 10126
average B-factor 125.0 188.0 243.0 221.2
R.m.s. deviations
 Bond lengths (Å) 0.007 0.007 0.007 0.010
 Bond angles (°) 0.85 0.87 0.87 1.01
aValues in parentheses are for highest-resolution shell.
bCriteria for data cutoff were from ref. 26.
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